Streamlining the delivery of advanced therapies is reliant upon a connected and transparent value chain of partners. TrakCel leverages partnerships with a wide range of cell and gene therapy service providers to provide a seamless end-to-end solution.
Connecting the Complex
Connect with a wide range of complementary service providers and scale your value chain with confidence. TrakCel’s Partner Ecosystem provides a seamless connection with end-to-end solutions for cell and gene therapies and personalized cancer vaccines.
Take advantage of TrakCel’s existing integrations, including contract manufacturers, specialty couriers, cold chain logistics, case management and other essential services to enhance control of the supply ecosystem.
the trakcel difference
Our Partner Ecosystem is continuously expanding.
Join our network and become TrakCel Ready!
Connect with a range of complementary services and systems
Leverage TrakCel’s existing partnerships for complete visibility of the value chain all from one platform
Seamless connections powered by Mulesoft
Integrate essential services and technologies faster via Mulesoft’s comprehensive integration platform
Data integrity at all times
TrakCel’s platform safely exchanges data with other cell and gene therapy software systems
TrakCel is committed to cell and gene therapy standardization and is continuously adding to its Partner Ecosystem
Powerful integration with an ecosystem of connected service companies
See What Our Partners Have To Say
At TrakCel, we are working with the goal of standardizing the delivery of life changing therapies to patients globally. By partnering with carefully selected companies and integrations we are always working to create seamless integrations to streamline the advanced therapy value chain.
"I have nothing but good things to say about TrakCel. The user interface is user-friendly and intuitive and the support provided has been great."
Wuxi Advanced Therapies
“The integration of TrakCel’s advanced therapy supply chain tracking software with the Ori full-stack platform is another step forward enabling our customers to have full visibility throughout the supply chain.”
"The cell and gene therapy industry continues experiencing exponential growth. As a fresh group of therapies moves towards commercialization, the supply ecosystem becomes more extensive. As a result, labeling standards have become critical to reduce risks, as specified by SCB and other organizations, BarTender will provide a vital component to OCELLOS by TrakCel to ensure the safety of patients, developers and all those within the value chain."
BarTender, Seagull Scientific
“Be The Match BioTherapies and TrakCel share the goal of ensuring that the next generation of cell and gene therapies can be developed efficiently and delivered to patients safely and reliably. This collaboration will allow us to develop the custom solutions best suited for each individual program and patient population.”
Be The Match BioTherapies
"The collaboration between Marken and TrakCel is a natural next step in our strategy to expand Marken's service offerings into the CGT clinical supply chain market. Our network of 49 global sites now include eight cryogenic (LN2) service stations and a very large and well-distributed fleet of specialty shipping containers to serve these trials. We also ensure 100% of all cell and gene shipments travel with our GPS tracking technology and are monitored by our 24/7 Global Control Center. We look forward to our new collaboration with TrakCel and what we can achieve together."
“Precision medicine and the delivery of innovative cell and gene therapies require a personalized approach, TrakCel’s robust data tracking and verification capabilities, combined with McKesson’s industry leading 3PL, specialty pharmacy solutions and patient support capabilities, are critical to helping manufacturers safely and effectively commercialize innovative new therapies. This integrated system will help prescribers and manufacturers work together seamlessly to ensure that the right patient always receives the correct therapeutic product at the right time.”
McKesson Life Sciences
“Quick Specialized Healthcare Logistics transports every year over 80,000 human organs and tissue samples. It is now essential not only to track the transport of these products that patient’s lives depend on but to offer every person involved in the supply of these products real-time information of the status and location of these products. Based on the continuously growing number of therapeutic companies currently working with TrakCel and Quick, we see this partnership and the work completed as a critical step forward for the industry.”
Quick Specialized Healthcare Logistics
“By incorporating links into the TrakCel solution we’ll provide on-tap access to cell therapy companies as they move through clinical trials to scaled production.”